The digestible sensor market size has grown rapidly in recent years. It will grow from $1.37 billion in 2025 to $1.56 billion in 2026 at a compound annual growth rate (CAGR) of 14%. The growth in the historic period can be attributed to limited availability of ingestible sensor technologies, reliance on conventional diagnostics methods, growing awareness of gi health, early adoption of capsule endoscopy, increasing r&d in bioelectronic interfaces.
The digestible sensor market size is expected to see rapid growth in the next few years. It will grow to $2.6 billion in 2030 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to advancements in wireless communication and mems technologies, integration with digital health platforms, expansion of personalized medicine initiatives, rising demand for real-time patient monitoring, growth in home healthcare and telemedicine. Major trends in the forecast period include increasing adoption of ingestible sensors for gi health monitoring, integration of sensors with drug adherence programs, expansion of smart capsule endoscopy applications, rising use of electrochemical and gas sensing technologies, growth in personalized patient monitoring solutions.
The growing demand for remote health monitoring is expected to drive the growth of the digestible sensor market in the coming years. Remote health monitoring involves the use of technology to track and manage a patient’s health outside conventional healthcare environments, typically at a distance. The increase in remote health monitoring is driven by patient preferences for personalized, real-time healthcare delivered from home, as well as the availability of cost-effective alternatives to traditional in-person consultations. Digestible sensors support remote health monitoring by enabling real-time measurement of internal health parameters, such as gastrointestinal activity, and by providing clinicians with valuable insights into a patient’s digestive health, allowing early identification of conditions such as infections or disease without the need for invasive procedures. For example, in August 2025, according to the Office of Inspector General, U.S. Department of Health & Human Services (OIG), Medicare expenditures for remote patient monitoring surpassed US$536 million in 2024, reflecting a 31% increase from 2023, nearly 1 million beneficiaries received RPM services, representing a 27% rise year over year, and approximately 4,600 medical practices regularly billed for RPM services. Therefore, the increasing demand for remote health monitoring is fueling the growth of the digestible sensor market.
The expanding demand for personalized medicine is expected to propel the growth of the digestible sensor market going forward. Personalized medicine is a healthcare approach that leverages information about an individual’s genetic makeup, lifestyle, and environment to customize medical treatments and care. The rise of personalized medicine is driven by growing consumer preference for health technologies that provide real-time monitoring and treatment strategies tailored to individual biological profiles. Digestible sensors facilitate personalized medicine by enabling physicians to gather real-time physiological data from within the body, supporting more precise diagnoses and individualized treatment plans based on each patient’s unique responses. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based professional membership organization, the U.S. Food and Drug Administration approved 16 new personalized therapies for rare disease patients in 2023, compared with six in 2022. Overall, the report documented 26 new personalized treatment approvals, 19 expanded indications for existing personalized medicines, and 17 major new or expanded indications for 12 diagnostic testing products. Therefore, the growing demand for personalized medicine is driving the growth of the digestible sensor market.
Major companies in the market are developing miniaturized, multi-parameter ingestible sensors to improve gut health monitoring and diagnostic accuracy. Multi-parameter sensors simultaneously measure multiple physical or chemical parameters in a compact device. For instance, in May 2025, the Interuniversity Microelectronics Centre in Belgium unveiled a highly miniaturized ingestible sensor measuring 2.1 cm in length and 0.75 cm in diameter about three times smaller than traditional endoscopic capsules. The capsule integrates sensors for oxidation-reduction potential (ORP), pH, and temperature, recording readings every 20 seconds throughout digestion. Equipped with wireless data transmission, a biocompatible casing, low-energy electronics, and a compact battery, it enables continuous, noninvasive monitoring of internal gut conditions, supporting early diagnosis of inflammation, oxidative stress, and microbiome imbalances.
Major companies operating in the digestible sensor market are Medtronic plc, Koninklijke Philips N.V., Otsuka Pharmaceutical Co Ltd, Olympus Corporation, Sencure B.V., Millar Inc., Check‑Cap Ltd, Proteus Digital Health Inc., CapsoVision Inc., Atmo Biosciences, IntroMedic Co Ltd, BodyCAP S.A.S., Capsule Technologies Inc., etectRx Inc., Motus GI Inc., SmartPill Corporation, JINSHAN Science & Technology Group Co Ltd, MC10, Medtronic GI Solutions, Proteus GI Technologies.
North America was the largest region in the digestible sensor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digestible sensor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digestible sensor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the digestible sensor market by increasing costs for imported microelectromechanical systems (MEMS), bioelectronic interfaces, and wireless components. Segments such as capsule sensors and ingestible sensors are most impacted, with regions like China and India facing higher import duties. These tariffs have led to supply chain challenges and higher product costs, but also promote local manufacturing, innovation in sensor design, and development of cost-effective domestic solutions.
The digestible sensor market research report is one of a series of new reports that provides digestible sensor market statistics, including digestible sensor industry global market size, regional shares, competitors with a digestible sensor market share, detailed digestible sensor market segments, market trends and opportunities, and any further data you may need to thrive in the digestible sensor industry. This digestible sensor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A digestible sensor is a small, ingestible electronic device designed to be swallowed to monitor internal health conditions or provide specific diagnostic information. These sensors are often embedded in pills and can measure physiological parameters such as temperature, pH, or medication adherence while passing through the gastrointestinal (GI) tract.
The primary types of digestible sensors include capsule sensors, wearable sensors, ingestible sensors, and implantable sensors. Capsule sensors are miniaturized, ingestible devices shaped like a capsule that travel through the GI tract. These devices are distributed through channels such as online retail, pharmacies, hospitals and clinics, and direct sales. They utilize technologies including microelectromechanical systems (MEMS), wireless communication, optical sensors, and bioelectronic interfaces, and are applied in medical diagnostics, drug delivery, patient monitoring, sports and fitness, and more, serving end users such as healthcare providers, research institutions, pharmaceutical companies, and individual consumers.
The digestible sensor market consists of sales of ingestion event marker (IEM), electronic pills, and ingestible thermometers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The digestible sensor market size is expected to see rapid growth in the next few years. It will grow to $2.6 billion in 2030 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to advancements in wireless communication and mems technologies, integration with digital health platforms, expansion of personalized medicine initiatives, rising demand for real-time patient monitoring, growth in home healthcare and telemedicine. Major trends in the forecast period include increasing adoption of ingestible sensors for gi health monitoring, integration of sensors with drug adherence programs, expansion of smart capsule endoscopy applications, rising use of electrochemical and gas sensing technologies, growth in personalized patient monitoring solutions.
The growing demand for remote health monitoring is expected to drive the growth of the digestible sensor market in the coming years. Remote health monitoring involves the use of technology to track and manage a patient’s health outside conventional healthcare environments, typically at a distance. The increase in remote health monitoring is driven by patient preferences for personalized, real-time healthcare delivered from home, as well as the availability of cost-effective alternatives to traditional in-person consultations. Digestible sensors support remote health monitoring by enabling real-time measurement of internal health parameters, such as gastrointestinal activity, and by providing clinicians with valuable insights into a patient’s digestive health, allowing early identification of conditions such as infections or disease without the need for invasive procedures. For example, in August 2025, according to the Office of Inspector General, U.S. Department of Health & Human Services (OIG), Medicare expenditures for remote patient monitoring surpassed US$536 million in 2024, reflecting a 31% increase from 2023, nearly 1 million beneficiaries received RPM services, representing a 27% rise year over year, and approximately 4,600 medical practices regularly billed for RPM services. Therefore, the increasing demand for remote health monitoring is fueling the growth of the digestible sensor market.
The expanding demand for personalized medicine is expected to propel the growth of the digestible sensor market going forward. Personalized medicine is a healthcare approach that leverages information about an individual’s genetic makeup, lifestyle, and environment to customize medical treatments and care. The rise of personalized medicine is driven by growing consumer preference for health technologies that provide real-time monitoring and treatment strategies tailored to individual biological profiles. Digestible sensors facilitate personalized medicine by enabling physicians to gather real-time physiological data from within the body, supporting more precise diagnoses and individualized treatment plans based on each patient’s unique responses. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based professional membership organization, the U.S. Food and Drug Administration approved 16 new personalized therapies for rare disease patients in 2023, compared with six in 2022. Overall, the report documented 26 new personalized treatment approvals, 19 expanded indications for existing personalized medicines, and 17 major new or expanded indications for 12 diagnostic testing products. Therefore, the growing demand for personalized medicine is driving the growth of the digestible sensor market.
Major companies in the market are developing miniaturized, multi-parameter ingestible sensors to improve gut health monitoring and diagnostic accuracy. Multi-parameter sensors simultaneously measure multiple physical or chemical parameters in a compact device. For instance, in May 2025, the Interuniversity Microelectronics Centre in Belgium unveiled a highly miniaturized ingestible sensor measuring 2.1 cm in length and 0.75 cm in diameter about three times smaller than traditional endoscopic capsules. The capsule integrates sensors for oxidation-reduction potential (ORP), pH, and temperature, recording readings every 20 seconds throughout digestion. Equipped with wireless data transmission, a biocompatible casing, low-energy electronics, and a compact battery, it enables continuous, noninvasive monitoring of internal gut conditions, supporting early diagnosis of inflammation, oxidative stress, and microbiome imbalances.
Major companies operating in the digestible sensor market are Medtronic plc, Koninklijke Philips N.V., Otsuka Pharmaceutical Co Ltd, Olympus Corporation, Sencure B.V., Millar Inc., Check‑Cap Ltd, Proteus Digital Health Inc., CapsoVision Inc., Atmo Biosciences, IntroMedic Co Ltd, BodyCAP S.A.S., Capsule Technologies Inc., etectRx Inc., Motus GI Inc., SmartPill Corporation, JINSHAN Science & Technology Group Co Ltd, MC10, Medtronic GI Solutions, Proteus GI Technologies.
North America was the largest region in the digestible sensor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digestible sensor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digestible sensor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the digestible sensor market by increasing costs for imported microelectromechanical systems (MEMS), bioelectronic interfaces, and wireless components. Segments such as capsule sensors and ingestible sensors are most impacted, with regions like China and India facing higher import duties. These tariffs have led to supply chain challenges and higher product costs, but also promote local manufacturing, innovation in sensor design, and development of cost-effective domestic solutions.
The digestible sensor market research report is one of a series of new reports that provides digestible sensor market statistics, including digestible sensor industry global market size, regional shares, competitors with a digestible sensor market share, detailed digestible sensor market segments, market trends and opportunities, and any further data you may need to thrive in the digestible sensor industry. This digestible sensor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A digestible sensor is a small, ingestible electronic device designed to be swallowed to monitor internal health conditions or provide specific diagnostic information. These sensors are often embedded in pills and can measure physiological parameters such as temperature, pH, or medication adherence while passing through the gastrointestinal (GI) tract.
The primary types of digestible sensors include capsule sensors, wearable sensors, ingestible sensors, and implantable sensors. Capsule sensors are miniaturized, ingestible devices shaped like a capsule that travel through the GI tract. These devices are distributed through channels such as online retail, pharmacies, hospitals and clinics, and direct sales. They utilize technologies including microelectromechanical systems (MEMS), wireless communication, optical sensors, and bioelectronic interfaces, and are applied in medical diagnostics, drug delivery, patient monitoring, sports and fitness, and more, serving end users such as healthcare providers, research institutions, pharmaceutical companies, and individual consumers.
The digestible sensor market consists of sales of ingestion event marker (IEM), electronic pills, and ingestible thermometers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Digestible Sensor Market Characteristics
3. Digestible Sensor Market Supply Chain Analysis
4. Global Digestible Sensor Market Trends and Strategies
5. Digestible Sensor Market Analysis of End Use Industries
7. Global Digestible Sensor Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Digestible Sensor Total Addressable Market (TAM) Analysis for the Market
9. Digestible Sensor Market Segmentation
10. Digestible Sensor Market Regional and Country Analysis
11. Asia-Pacific Digestible Sensor Market
12. China Digestible Sensor Market
13. India Digestible Sensor Market
14. Japan Digestible Sensor Market
15. Australia Digestible Sensor Market
16. Indonesia Digestible Sensor Market
17. South Korea Digestible Sensor Market
18. Taiwan Digestible Sensor Market
19. South East Asia Digestible Sensor Market
20. Western Europe Digestible Sensor Market
21. UK Digestible Sensor Market
22. Germany Digestible Sensor Market
23. France Digestible Sensor Market
24. Italy Digestible Sensor Market
25. Spain Digestible Sensor Market
26. Eastern Europe Digestible Sensor Market
27. Russia Digestible Sensor Market
28. North America Digestible Sensor Market
29. USA Digestible Sensor Market
30. Canada Digestible Sensor Market
31. South America Digestible Sensor Market
32. Brazil Digestible Sensor Market
33. Middle East Digestible Sensor Market
34. Africa Digestible Sensor Market
36. Digestible Sensor Market Competitive Landscape and Company Profiles
37. Digestible Sensor Market Other Major and Innovative Companies
40. Digestible Sensor Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Digestible Sensor Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses digestible sensor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for digestible sensor? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digestible sensor market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Capsule Sensors; Wearable Sensors; Ingestible Sensors; Implantable Sensors2) By Distribution Channel: Online Retail; Pharmacies; Hospitals And Clinics; Direct Sales
3) By Technology: Microelectromechanical Systems (MEMS); Wireless Communication Technologies; Optical Sensors; Bioelectronic Interfaces
4) By Application: Medical Diagnostics; Drug Delivery; Patient Monitoring; Sports And Fitness; Other Applications
5) By End-User: Healthcare Providers; Research Institutions; Pharmaceutical Companies; Individual Consumers
Subsegments:
1) By Capsule Sensors: pH Monitoring Capsules; Temperature Monitoring Capsules; Pressure Sensing Capsules; Smart Capsule Endoscopy; Drug Delivery Capsules With Sensors2) By Wearable Sensors: Patch-Based External Receivers; Gastrointestinal Motility Trackers; Bio-Signal Monitoring Wearables; Wearable Adherence Trackers
3) By Ingestible Sensors: Vital Sign Monitoring Sensors; Drug Adherence Monitoring Sensors; Imaging Sensors; Gas Sensing Sensors; Electrochemical Sensors
4) By Implantable Sensors: GI Electrophysiology Sensors; pH And Enzyme Sensors; Neuromodulation Devices; Metabolic Sensors
Companies Mentioned: Medtronic plc; Koninklijke Philips N.V.; Otsuka Pharmaceutical Co Ltd; Olympus Corporation; Sencure B.V.; Millar Inc.; Check‑Cap Ltd; Proteus Digital Health Inc.; CapsoVision Inc.; Atmo Biosciences; IntroMedic Co Ltd; BodyCAP S.A.S.; Capsule Technologies Inc.; etectRx Inc.; Motus GI Inc.; SmartPill Corporation; JINSHAN Science & Technology Group Co Ltd; MC10; Medtronic GI Solutions; Proteus GI Technologies
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Digestible Sensor market report include:- Medtronic plc
- Koninklijke Philips N.V.
- Otsuka Pharmaceutical Co Ltd
- Olympus Corporation
- Sencure B.V.
- Millar Inc.
- Check‑Cap Ltd
- Proteus Digital Health Inc.
- CapsoVision Inc.
- Atmo Biosciences
- IntroMedic Co Ltd
- BodyCAP S.A.S.
- Capsule Technologies Inc.
- etectRx Inc.
- Motus GI Inc.
- SmartPill Corporation
- JINSHAN Science & Technology Group Co Ltd
- MC10
- Medtronic GI Solutions
- Proteus GI Technologies
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.56 Billion |
| Forecasted Market Value ( USD | $ 2.6 Billion |
| Compound Annual Growth Rate | 13.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
